Washington Examiner: Gwen Moore reveals cancer prognosis during Ways and Means Committee hearing

Washington Examiner - A Wisconsin Democrat announced Tuesday she was in remission after an almost yearlong fight against a cancer that was attacking her immune system.
Naomi Lin
Washington Examiner

A Wisconsin Democrat announced Tuesday she was in remission after an almost yearlong fight against a cancer that was attacking her immune system.

"I’m so glad to be here. And when I say I am glad to be here, I mean I am glad to be here," Rep. Gwen Moore, D-Wis., said during the Ways and Means Committee's first hearing of the 116th Congress, according to the Milwaukee Journal Sentinel. The panel had been convened to examine health insurance and pre-existing conditions coverage.

"Literally instead of yielding me time, you could be delivering kind words at my memorial service. In the spring of 2018, I joined an exclusive club of millions of Americans with the cursed 'C' disease, cancer, a disease that guarantees discrimination in the insurance marketplace, for many a death sentence," she told those in attendance of her small cell lymphoma diagnosis.

But Moore, 67, who was first elected to Congress in 2004, said Tuesday she was now "in great health with an excellent prognosis of living with this disease."

In a statement explaining her decision to go public with her recent scare, she said, “Ways and Means Republicans have voted to defund, undercut, and undermine our country’s health care system."

"They have made it clear as day that they care more about the cost of the ACA than the value of human life," Moore wrote, referring to former President Barack Obama's signature healthcare reform, the Affordable Care Act. "I am announcing my remission today to remind everyone on this committee that I am a living example of the lifesaving value of essential health benefits. For my children, grandchildren, and great-grandchildren that is a cost worth paying."

To read online, click here

Stay Connected

Use the form below to sign up for my newsletter and get the latest news and updates directly to your inbox.